Previous studies demonstrated that higher GPC-3 expression level in HCC was a risk factor for shorter overall survival and GPC-3 expression level in poorly-differentiated tumor cells was higher than that in moderately- and well- differentiated HCC [32–34]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.